Leveraging Next-Generation Sequencing for mRNA Vaccine Characterization & Quality Control
Time: 12:00 pm
day: Conference Day Two
Details:
- Understanding how NGS is being used, and for which quality aspects, for mRNA vaccine development and manufacturing
- Addressing current challenges using NGS for mRNA vaccine characterization and quality control
- Progressing analytical validation of NGS to ensure vaccine identity and fidelity
